Delivery Order SPE2DB24D3013-SPE2DB26FFFQA
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a contract ceiling value of $10,113.96. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 30,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $2,219.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies an ultimate completion date of October 20, 2025, and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $25,843.36. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of July 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets in quantities of 90 units, with a contract ceiling value of $2,211.60. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Januvia 25 mg tablets (90-count) under a firm fixed-price contract valued at $2,977.41. This delivery order represents a child contract action issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, which serves as the company's corporate...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $7,042.85 by the Defense Logistics Agency on May 20, 2025, for the supply of Januvia 100 mg tablets (90-count). The contract is scheduled for completion by May 21, 2025, and involves no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFQADelivery Order
AmerisourceBergen Drug Corp was awarded a $2,425.00 delivery order by the Defense Logistics Agency (DLA) on October 17, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price contract with an ultimate completion date of October 20, 2025, and represents a child contract under a larger indefinite delivery vehicle. The award was made through competitive procurement with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports comprehensive pharmaceutical distribution to military healthcare systems worldwide, encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Januvia supply aligns with the DLA's support of federal military and veteran healthcare operations, enabling the Defense Health Agency and related federal health systems to access essential diabetes management medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/17/25 |